Page last updated: 2024-10-24

adenosine transport

Definition

Target type: biologicalprocess

The directed movement of adenosine, adenine riboside, into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore. [GOC:mah]

Adenosine transport is a fundamental process in cellular physiology, involving the movement of adenosine across cell membranes. Adenosine, a purine nucleoside, plays a crucial role in various biological processes, including neurotransmission, inflammation, and energy metabolism. The transport of adenosine across cell membranes is mediated by a family of membrane-bound proteins known as nucleoside transporters (NTs). These transporters are responsible for the uptake and efflux of adenosine and other nucleosides, contributing to the regulation of adenosine levels both intracellularly and extracellularly.

There are two main types of adenosine transporters: equilibrative nucleoside transporters (ENTs) and concentrative nucleoside transporters (CNTs). ENTs facilitate the bidirectional transport of adenosine across the membrane, driven by the concentration gradient. They do not require energy and are responsible for the passive diffusion of adenosine. CNTs, on the other hand, are active transporters that utilize energy from the hydrolysis of ATP to transport adenosine against its concentration gradient. This allows for the accumulation of adenosine inside cells.

ENTs are further subdivided into two subtypes: ENT1 and ENT2. ENT1 is the most abundant nucleoside transporter in many tissues, including the brain, heart, and skeletal muscle. It exhibits a high affinity for adenosine and plays a significant role in the regulation of extracellular adenosine levels. ENT2 is less abundant and exhibits lower affinity for adenosine compared to ENT1. It is primarily involved in the uptake of adenosine in the liver and kidney.

CNTs are also classified into subtypes: CNT1, CNT2, and CNT3. CNT1 is the primary transporter responsible for the uptake of adenosine in the intestine and kidney. It exhibits a high affinity for adenosine and plays a crucial role in the absorption of adenosine from the diet. CNT2 is expressed in the brain, heart, and skeletal muscle. It transports adenosine with a lower affinity compared to CNT1. CNT3 is primarily localized to the liver and kidney and exhibits a low affinity for adenosine.

The transport of adenosine across cell membranes is a complex process regulated by various factors, including the concentration of adenosine, the expression levels of nucleoside transporters, and the presence of inhibitors. Dysregulation of adenosine transport can lead to various pathological conditions, such as neurodegenerative diseases, cardiovascular diseases, and inflammatory disorders. Therefore, understanding the mechanisms of adenosine transport is crucial for developing novel therapeutic strategies targeting these diseases.
'
"

Proteins (4)

ProteinDefinitionTaxonomy
Equilibrative nucleoside transporter 1An equilibrative nucleoside transporter 1 that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q99808]Homo sapiens (human)
Equilibrative nucleoside transporter 4An equilibrative nucleoside transporter 4 that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q7RTT9]Homo sapiens (human)
Equilibrative nucleoside transporter 2An equilibrative nucleoside transporter 2 that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q14542]Homo sapiens (human)
Sodium/nucleoside cotransporter 2A sodium/nucleoside cotransporter 2 that is encoded in the genome of human. [PRO:DNx, UniProtKB:O43868]Homo sapiens (human)

Compounds (22)

CompoundDefinitionClassesRoles
histaminearalkylamino compound;
imidazoles
human metabolite;
mouse metabolite;
neurotransmitter
dilazepdilazep : A member of the class of diazepanes that is 1,4-diazepane substituted by 3-[(3,4,5-trimethoxybenzoyl)oxy]propyl groups at positions 1 and 4. It is a potent adenosine uptake inhibitor that exhibits antiplatelet, antianginal and vasodilator properties.

Dilazep: Coronary vasodilator with some antiarrhythmic activity.
benzoate ester;
diazepane;
diester;
methoxybenzenes
cardioprotective agent;
platelet aggregation inhibitor;
vasodilator agent
dipyridamoledipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.

Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
piperidines;
pyrimidopyrimidine;
tertiary amino compound;
tetrol
adenosine phosphodiesterase inhibitor;
EC 3.5.4.4 (adenosine deaminase) inhibitor;
platelet aggregation inhibitor;
vasodilator agent
lidoflazineLidoflazine: Coronary vasodilator with some antiarrhythmic action.diarylmethane
floxuridinefloxuridine : A pyrimidine 2'-deoxyribonucleoside compound having 5-fluorouracil as the nucleobase; used to treat hepatic metastases of gastrointestinal adenocarcinomas and for palliation in malignant neoplasms of the liver and gastrointestinal tract.

Floxuridine: An antineoplastic antimetabolite that is metabolized to fluorouracil when administered by rapid injection; when administered by slow, continuous, intra-arterial infusion, it is converted to floxuridine monophosphate. It has been used to treat hepatic metastases of gastrointestinal adenocarcinomas and for palliation in malignant neoplasms of the liver and gastrointestinal tract.
nucleoside analogue;
organofluorine compound;
pyrimidine 2'-deoxyribonucleoside
antimetabolite;
antineoplastic agent;
antiviral drug;
radiosensitizing agent
uridineuridinesdrug metabolite;
fundamental metabolite;
human metabolite
phlorhizinaryl beta-D-glucoside;
dihydrochalcones;
monosaccharide derivative
antioxidant;
plant metabolite
methylthioinosineMethylthioinosine: 6-(Methylthio)-9-beta-D-ribofuranosylpurine. An analog of inosine with a methylthio group replacing the hydroxyl group in the 6-position.purine ribonucleoside;
thiopurine
hyaluronoglucosaminidasekinetin riboside: preferentially induces apoptosis by modulating Bcl-2 family proteins and caspase-3 in cancer cells; structure in first sourcepurine nucleoside
gemcitabinegemcitabine : A 2'-deoxycytidine having geminal fluoro substituents in the 2'-position. An inhibitor of ribonucleotide reductase, gemcitabine is used in the treatment of various carcinomas, particularly non-small cell lung cancer, pancreatic cancer, bladder cancer and breast cancer.organofluorine compound;
pyrimidine 2'-deoxyribonucleoside
antimetabolite;
antineoplastic agent;
antiviral drug;
DNA synthesis inhibitor;
EC 1.17.4.1 (ribonucleoside-diphosphate reductase) inhibitor;
environmental contaminant;
immunosuppressive agent;
photosensitizing agent;
prodrug;
radiosensitizing agent;
xenobiotic
draflazinedraflazine: a nucleoside transport inhibitor; has cardioprotective effect; draflazine is the (-)-enantiomer; R 88016 is the (+)-enantiomer
adenosinequinquefolan B: isolated from roots of Panax quinquefolium L.; RN not in Chemline 10/87; RN from Toxlitadenosines;
purines D-ribonucleoside
analgesic;
anti-arrhythmia drug;
fundamental metabolite;
human metabolite;
vasodilator agent
4-nitrobenzylthioinosine4-nitrobenzylthioinosine: inhibitor of nucleoside transport; acts on ENT1purine nucleoside
n(6)-benzyladenosineN(6)-benzyladenosine: RN given refers to parent cpd
6-(4-nitrobenzylthio)guanosine6-(4-nitrobenzylthio)guanosine: inhibitor of nucleoside transport
5-iodotubercidin7-iodotubercidin: inhibits Toxoplasma gondii adenosine kinaseorganoiodine compound
n(6)-phenyladenosinepurine nucleoside
tecadenosontecadenoson: an A1 adenosine receptor agonist
2-hydroxy-5-nitrobenzylthioguanosine
n(6)-cyclopentyladenosine
7,8,3'-trihydroxyflavone7,8,3'-trihydroxyflavone: a potent small molecule TrkB receptor agonist that protects spiral ganglion neurons from degeneration both in vitro and in vivo
6-benzylthioinosine6-benzylthioinosine: a subversive substrate of T gondii adenosine kinase; structure in first source